載入...

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

A cornerstone of preclinical cancer research has been the use of clonal cell lines. However, this resource has underperformed in its ability to effectively identify novel therapeutics and evaluate the heterogeneity in a patient's tumor. The patient-derived xenograft (PDX) model retains the hete...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Dobbin, Zachary C., Katre, Ashwini A., Steg, Adam D., Erickson, Britt K., Shah, Monjri M., Alvarez, Ronald D., Conner, Michael G., Schneider, David, Chen, Dongquan, Landen, Charles N.
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2014
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226719/
https://ncbi.nlm.nih.gov/pubmed/25209969
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!